LONDON (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research, Stock Buzz) has sold four of its older drugs to a unit of South Africa’s Aspen Pharmacare Holdings (APNJ.J: Quote, Profile, Research, Stock Buzz) for 170 million pounds ($339 million), the world’s second biggest drugmaker said on Monday. The medicines involved are Eltroxin, a thyroid hormone for hyperthyroidism; Lanoxin, a cardiac glycoside for heart failure; Imuran, an immunosuppressant; and Zyloric, an enzyme inhibitor for the treatment of gout.
